Business
Klea Holding : Klea Holding accelerates its growth in the first half of 2025
Klea Holding : Klea Holding accelerates its growth in the first half of
About this update from Klea Holding
[{"type":"text","content":"\n\tNumber of tests performed up by +55% compared with +24% in 2024;\n\tSales up +48% at constant exchange rates;\n\tConfirmation of development and performance plan.\nParis, 21 July 2025\nKLEA HOLDING (FR0013481835 - ALKLH), a group specialising in the acquisition, development and digitalisation of companies in various sectors, presents its unaudited sales figures for the first half of 2025.Acceleration in the volume of tests carried out Number of tests performed (in volume)H1 2024H1 2025Var. 25/24Medical Fitness tests\n\t\t68,515\n\t\t105,342\n\t\t+54%Health & Wellness tests\n\t\t1,698\n\t\t3,712\n\t\t+119%Total number of tests performed70,213109,054+55 %\nThe volume of tests carried out in the 3 Smart Salem medical centres in Dubai increased by +55% between the first half of 2024 and the first half of 2025. This performance confirms the continued growth in Medical Fitness tests (+54%) and the rise in Health Check tests (+119%).\nThis remarkable performance comes on the back of +24% annual growth in 2024 and +31% growth in the first quarter of 2025.Strong sales growth despite unfavourable currency impactAt 30 June - €m – unaudited financialsH1 2024[1]H1 2025[2]Var. 25/24\npublishedVar. 25/24 cst. rateMedical Fitness segment\n\t\t7.5\n\t\t10.3\n\t\t+37%\n\t\t+39%Health & Wellness tests and other segments\n\t\t0.4\n\t\t0.9\n\t\t+139%\n\t\t+142%\n\t\tOther revenues[3]\n\t\t0.0\n\t\t0.3\n\t\t-\n\t\t-Klea Holding consolidated sales7.911.5+46%+48%\nOn the back of this increase in the number of tests, half-year sales reached €11.5m, up +46% on a reported basis, taking into account the unfavourable impact of exchange rates. At constant exchange rates, sales growth was +48%.\nSmart Salem is also benefiting from the first revenues from the new services developed since 2024, in particular around occupational health tests.Confirmation of objectives\nKlea Holding confirms the elements of its roadmap unveiled at the last Annual General Meeting of Shareholders, at which Raphael Smila, a director and the largest shareholder controlling more than 20% of the company's capital, was appointed Chairman and CEO.\nThis plan is based on the following elements:Drastic cost reductions at Klea Holding and its subsidiaries.\n\tEBITDA 2025 expected to improve significantly.\n\tContinued and accelerated deleveraging of the Group...